This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.
This study is looking at how our immune system functions when we are coinfected with both HIV and either hepatitis B or C.
It might show us how some people can clear hepatitis from their system when they're on treatment while others can when they're not.
A Study of Innate Immunity in HIV Positive Patients co-Infected With Hepatitis C or Hepatitis B
other – innate immunity
40 (The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.)
Participants in this trial will be asked to follow the trial protocol for 6 months.
You may be eligible to participate in this trial if you meet the following criteria:
This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.
Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.
While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.
Before making the decision to participate in any clinical research, visit the NAPWA website for background information on participating in clinical research.
Contact NAPWA if you have any questions or comments about this trial.